Latest / Decera Clinical Education Oncology Podcast
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States
In this episode, Petros Grivas, MD, PhD, and Jonathan E. Rosenberg, MD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma informing their clinical practice in the United States. Topics include:
Guideline changes for first-line UC based on data from JAVELIN Bladder 100 trial on avelumab maintenance after chemotherapy
Results from IMvigor130 and KEYNOTE-361 trials on concurrent immune checkpoint inhibition plus chemotherapy
When to consider first-line treatment with immune checkpoint inhibitor monotherapy
Utility of PD-L1 as biomarker for immune checkpoint…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.